Skip to main content
. Author manuscript; available in PMC: 2017 Feb 9.
Published in final edited form as: Invest New Drugs. 2010 Aug 10;30(1):258–265. doi: 10.1007/s10637-010-9504-5

Table 3.

Dose limiting toxicities

Dose level # patients DLT
1* 8 2 Neutropenic Fever
2 4 2 Neutropenic Fever
2A 5 2 Neutropenic Fever and Weakness
2B 2 1 Neutropenic Fever